Enterprising achievements accordion

The Monash-Moderna Quantitative Pharmacology Accelerator (MMQPA), established in August, extended the University’s collaboration with Moderna. This five-year program aims to drive advancements in mRNA medicines.

The MMQPA is the inaugural research and development (R&D) accelerator initiative from Moderna’s global R&D organisation in Australia, enabling the development of new, safe and effective mRNA medicines for a broad range of diseases

Find out more

The Victorian Government, Monash Health and Monash University are tripartite partners in the $577 million Victorian Heart Hospital (VHH) project, and after a decade of planning, the VHH opened on our Clayton campus. The first patients were welcomed in February 2023.

The VHH’s strength is its unique model, which brings together clinical care with research, education and training to accelerate the translation of discoveries.

Find out more

We’ve significantly increased access to crucial early-stage investment capital for Monash spinouts with the announcement of a dedicated pre-seed fund with Breakthrough Victoria in September and officially joining the UniSeed investment fund in November.

These partnerships help us nurture and accelerate the growth of current and future startup and spinout companies, and enhance our ability to create a lasting and positive societal impact.

Find out more